ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 75 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90,180 | -53.3% | 60,120 | -50.5% | 0.02% | -56.2% |
| Q2 2023 | $193,015 | +121.6% | 121,393 | 0.0% | 0.05% | +108.7% |
| Q1 2023 | $87,088 | +23.8% | 121,393 | 0.0% | 0.02% | +9.5% |
| Q4 2022 | $70,347 | -23.5% | 121,393 | +25.3% | 0.02% | -27.6% |
| Q3 2022 | $92,000 | -42.1% | 96,910 | -27.0% | 0.03% | -35.6% |
| Q2 2022 | $159,000 | +84.9% | 132,769 | +101.9% | 0.04% | +125.0% |
| Q1 2022 | $86,000 | -9.5% | 65,754 | +21.8% | 0.02% | 0.0% |
| Q4 2021 | $95,000 | -4.0% | 54,000 | +18.4% | 0.02% | -9.1% |
| Q3 2021 | $99,000 | +4.2% | 45,603 | +75.4% | 0.02% | -38.9% |
| Q3 2017 | $95,000 | +46.2% | 25,998 | 0.0% | 0.04% | +33.3% |
| Q2 2017 | $65,000 | +1.6% | 25,998 | +9.5% | 0.03% | +3.8% |
| Q1 2017 | $64,000 | – | 23,746 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,112,355 | $40,178,000 | 34.81% |
| Versant Venture Management, LLC | 7,068,233 | $69,056,636,000 | 18.94% |
| ACUTA CAPITAL PARTNERS, LLC | 1,704,500 | $16,653,000 | 8.07% |
| Soleus Capital Management, L.P. | 313,900 | $3,067,000 | 3.57% |
| Ghost Tree Capital, LLC | 1,305,500 | $12,755,000 | 3.38% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,690,000 | 2.97% |
| RTW INVESTMENTS, LP | 6,631,627 | $64,791,000 | 2.79% |
| VR Adviser, LLC | 994,381 | $9,715,000 | 2.63% |
| Avoro Capital Advisors LLC | 7,150,000 | $69,856,000 | 2.36% |
| RA Capital Management | 7,272,714 | $71,054,000 | 2.24% |